Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
F.C.P.S. (Medicine), M.D (Gastroentology)
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Certified Diabetologist (UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Certified Diabetologist (UK)
Internal Medicine Specialist
M.B.B.S. M.R.C.P (UK), M.C.C.E.E (Canada), F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S. M.R.C.P (UK), M.C.C.E.E (Canada), F.C.P.S (Medicine)
Hepatologist
M.B.B.S, F.C.P.S (Gastroenterology)
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Internal Medicine Specialist
MBBS, MRCP (UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (UK)
General Physician
MBBS, F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures